CHARACTERIZATION OF HISTAMINE H1-RECEPTOR AND H2-RECEPTOR IN THE RABBIT ISOLATED OVARIAN ARTERY AND VEIN

被引：8
作者：
ORIOWO, MA [1 ]
BEVAN, JA [1 ]
机构：
[1] UNIV VERMONT,COLL MED,DEPT PHARMACOL,BURLINGTON,VT 05405
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1987年 / 10卷 / 01期
关键词：
D O I：
10.1097/00005344-198707000-00011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 81
页数：6
相关论文
共 27 条
[1]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[2]   RECEPTORS MEDIATING SOME ACTIONS OF HISTAMINE [J].
ASH, ASF ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1966, 27 (02) :427-&
[3]   DIRECT METHOD FOR RECORDING TENSION CHANGES IN WALL OF SMALL BLOOD-VESSELS IN-VITRO [J].
BEVAN, JA ;
OSHER, JV .
AGENTS AND ACTIONS, 1972, 2 (05) :257-+
[4]   METIAMIDE - ORALLY ACTIVE HISTAMINE H2-RECEPTOR ANTAGONIST [J].
BLACK, JW ;
DUNCAN, WAM ;
EMMETT, JC ;
GANELLIN, CR ;
HESSELBO, T ;
PARSONS, ME ;
WYLLIE, JH .
AGENTS AND ACTIONS, 1973, 3 (03) :133-137
[5]   THE ANTAGONISM OF HISTAMINE-INDUCED TRACHEAL AND BRONCHIAL MUSCLE-CONTRACTION BY DIPHENHYDRAMINE - EFFECT OF MATURATION [J].
DOUGLAS, JS ;
DUNCAN, PG ;
MUKHOPADHYAY, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 83 (03) :697-705
[6]   IMPROMIDINE (SK AND F 92676) IS A VERY POTENT AND SPECIFIC AGONIST FOR HISTAMINE H-2 RECEPTORS [J].
DURANT, GJ ;
DUNCAN, WAM ;
GANELLIN, CR ;
PARSONS, ME ;
BLAKEMORE, RC ;
RASMUSSEN, AC .
NATURE, 1978, 276 (5686) :403-405
[7]   CHEMICAL DIFFERENTIATION OF HISTAMINE H1-RECEPTOR AND H2-RECEPTOR AGONISTS [J].
DURANT, GJ ;
GANELLIN, CR ;
PARSONS, ME .
JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (09) :905-909
[8]   PHARMACOLOGIC COMPARISON OF HISTAMINE RECEPTORS IN ISOLATED EXTRACRANIAL AND INTRACRANIAL-ARTERIES INVITRO [J].
EDVINSSON, L ;
OWMAN, C .
NEUROLOGY, 1975, 25 (03) :271-276
[9]   OVULATION AS AN INFLAMMATORY REACTION - HYPOTHESIS [J].
ESPEY, LL .
BIOLOGY OF REPRODUCTION, 1980, 22 (01) :73-106
[10]  
Furchgott RF, 1972, HDB EXPT PHARM, V3, P283
123